Loading
A phase 2/3 trial of Tozuleristide run by Blaze Bioscience Inc., completed.
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery is a phase 2/3 interventional study registered as NCT03579602 by Blaze Bioscience Inc., with 118 participants enrolled, started 2018-11-26. Conditions recorded: Pediatric Central Nervous System Tumor. Interventions recorded: tozuleristide and Canvas System.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/